Market revenue in 2023 | USD 739.9 million |
Market revenue in 2030 | USD 1,275.8 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Acute wounds |
Fastest growing segment | Acute Wounds |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Acute Wounds |
Key market players worldwide | Smith & Nephew PLC, Teva Pharmaceutical Industries Ltd, Molina Healthcare Inc, Arch Therapeutics Inc, Viatris Inc, AstraZeneca PLC, Osiris Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to topical wound agents market will help companies and investors design strategic landscapes.
Acute wounds was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America topical wound agents market based on acute wounds covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America topical wound agents market , including forecasts for subscribers. This continent databook contains high-level insights into North America topical wound agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account